Today, leading crowdfunding platform OurCrowd is sharing the news that their portfolio company Sight Diagnostics is succeeding where Theranos failed.
Read more here.
Today, leading crowdfunding platform OurCrowd is sharing the news that their portfolio company Sight Diagnostics is succeeding where Theranos failed.
Read more here.
![[Intuition Robotics in VentureBeat] Intuition Robotics nabs Samsung as investor, launches U.S. beta trial of ElliQ companion robot](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
